DT U.S. Edition, November 2010, Vol. 5, No. 22

Industry Meeting Review DENTAL TRIBUNE | November 201012A The opening plenary session, ‘Xerostomia and Hyposalivation: Mechanisms and Solutions,’ at the European Association of Oral Medicine Meeting Xerostomia and hyposalivation are not such ‘dry’ subjects By Lisa Townshend, Dental Tribune U.K. Edition The 10th biannual meeting of the European Association of Oral Medi- cine (EAOM), held in London, was a truly collaborative effort. Organ- ised by the EAOM and London’s three dental schools (King’s College London, Queen Mary University of London and the Eastman Dental Institute of University College Lon- don) and supported by GSK, the conference highlighted the impor- tance of oral medicine in diagnos- ing and treating conditions such as xerostomia and hyposalivation. The opening plenary session of the main part of the conference was dedicated to this topic. After open- ing remarks by Baroness Gardner of Parkes and Chief Dental Officer for England Dr. Barry Cockcroft, it was time to turn over the session to the two chairs, Prof. Isaäc van der Waal (head of the department of oral and maxillofacial surgery and oral pathology of the VU Uni- versity Medical Center/ACTA Den- tal School, Amsterdam) and Prof. Crispian Scully, CBE (director of special projects at the UCL-East- man Dental Institute and professor of special care dentistry, University College London). After setting the scene for the session, they introduced the first speaker, Prof. Stephen Porter. Porter is director and professor of oral medicine of UCL Eastman Dental Institute. His presenta- tion, “Hyposalivation: Prevalence, assessment, differential diagnosis and quality of life impact,” gave a general overview of the problem of xerostomia in terms of prevalence. He discussed the age factor in the condition, as well as issues such as immuno-suppressant dis- ease and drug/radiotherapy treat- ments. He also looked at the issue AD tal profession, which evaluates patient maturity and stability, obtains and evaluates a credit report, and returns a credit “grade” and a payment plan recommendation in seconds. ZACC evaluates credit risk in exactly the same fashion as a bank loan officer, but does not affect your patient’s credit score. To learn more about ZACC, visit www.getzacc.com. DT f DT page 11A Paul Zuelke is president and founder of Zuelke & Associates, a management consulting firm spe- cializing exclusively in teaching credit management and accounts receivable control techniques to health-care practices. Zuelke’s extensive, profes- sional background in lending and corporate finance, combined with 30 years of experience with more than 1,000 client practices located throughout the United States, Can- ada and Australia, positions him as the leading authority in using effec- tive credit management to build a quality health-care practice. About the author